Search

Search Constraints

You searched for: Author/Creator Jones, E

Search Results

3. 263TiPATHENA (GOG-3020/ENGOT-ov45): A randomised, double-blind, placebo-controlled phase III study of the poly (ADP-ribose) polymerase (PARP) inhibitor rucaparib + the PD-1 inhibitor nivolumab following frontline platinum-based chemotherapy in ovarian cancer. (24th November 2019)

4. 290 Are obstetrics and gynaecology trainees confident and competent in the care of frail gynaecological oncology patients?. (13th November 2020)